Vergoeding 2018-2022 voor ATC-subgroep B01A : Antithrombotica
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| B01AA Vitamine k-antagonisten | 4.027.300 | 3.659.900 | 3.344.700 | 3.210.600 | 2.674.500 |
| B01AB Heparinegroep | 24.688.700 | 21.601.200 | 18.017.700 | 16.137.400 | 16.799.900 |
| B01AC Trombocytenaggregatieremmers excl heparine | 54.783.600 | 52.701.100 | 50.402.000 | 49.392.600 | 53.268.900 |
| B01AD Enzymen | 2.655 | . | 3.172 | 13.662 | 16.825 |
| B01AE Directe trombineremmers | 37.162.600 | 39.982.000 | 36.107.300 | 30.951.300 | 30.745.200 |
| B01AF Directe remmers van factor xa | 118.675.700 | 158.705.900 | 191.925.900 | 221.646.100 | 257.448.700 |
| B01AX Overige antithrombotica | 853.380 | 731.940 | 597.250 | 679.620 | 669.660 |
| Totaal | 240.193.935 | 277.382.040 | 300.398.022 | 322.031.282 | 361.623.685 |